News | Cardiovascular Ultrasound | February 26, 2018

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

WASE Normal Values Study will assess whether current recommended normal values for heart dimensions and function are adequate, develop normal values for novel modalities like 3-D and strain

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joining efforts in the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. This study is bringing together the scientific cardiovascular ultrasound community from around the world to better understand if the current recommended normal values for heart dimensions and function in subjects from different races and countries are similar or different. In addition, normal values for novel echocardiography modalities such as 3-D and strain will be established.

Principal investigators Roberto M. Lang, M.D., FASE, University of Chicago Medical Center, and Federico M. Asch, M.D., FASE, MedStar Health Research Institute in Washington, D.C.,announced that the WASE study has enrolled the landmark number of 1,000 subjects. Asch said, “This represents over 50 percent of our target. We are hoping to complete enrollment by the end of this year. Individuals from six continents have been enrolled and initial preliminary findings will be presented at the ASE 2018 Scientific Sessions in Nashville this June.” Final results are expected to be available in 2019.

The WASE Normal Values Study entails the acquisition of complete 2-D and 3-D echocardiograms in 100 healthy individuals of both genders and across a wide range of ages in each of 17 countries. All echoes will be analyzed in collaboration with MedStar Health and the University of Chicago. The clinical usefulness of echocardiography is based on the detection of abnormalities, which relies on the accurate definition of “normality” across different countries or races. Currently, available echocardiographic “reference values” that define “normality” are mostly based on cross-sectional observations of Caucasians from the U.S. and Europe.

Robin Wiegerink, CEO of ASE said, “This study provides unique opportunities to interact with our global partners to facilitate scientific collaborations and strengthen relationships, with the goal of improved patient care. The ASE International Alliance Partners program was developed to foster this kind of interaction and create synergies that could be replicated in future standardization projects.”

The WASE Normal Values Study is being funded by the American Society of Echocardiography Foundation and its donors, and with in-kind support from sponsors Tomtec Imaging Systems, Medidata, MedStar Health and University of Chicago.

For more information: www.asecho.org

 


Related Content

Feature | Cardiovascular Ultrasound | Kyle Hardner

The demand for ultrasound has outpaced the supply of trained sonographers over the past 15 years, straining hospital ...

Home March 11, 2026
Home
News | Cardiovascular Ultrasound

Septe. 30, 2025 -- GE HealthCare Vivid iq Ultrasound system has been selected by NASA for delivery to the International ...

Home October 09, 2025
Home
News | Cardiovascular Ultrasound

Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded ...

Home October 03, 2025
Home
News | Cardiovascular Ultrasound

Aug. 27, 2025 — Royal Philips has released Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx ...

Home August 27, 2025
Home
News | Cardiovascular Ultrasound

Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and ...

Home August 14, 2025
Home
News | Cardiovascular Ultrasound

March 24, 2025 — FUJIFILM Healthcare Americas Corp. and Us2.ai have partnered to equip Fujifilm’s LISENDO 800 ...

Home March 24, 2025
Home
News | Cardiovascular Ultrasound

Feb. 11, 2025 — UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound ...

Home February 18, 2025
Home
News | Cardiovascular Ultrasound

May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...

Home May 30, 2024
Home
News | Cardiovascular Ultrasound

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

Home April 05, 2024
Home
News | Cardiovascular Ultrasound

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

Home August 24, 2023
Home
Subscribe Now